Who Paid My Doc
Palforzia
Biological Allergy
NDC 71881-113-13
General payments
$892,057
Research payments
$7,700,004
Through program year 2024, $892,057 in general payments and $7,700,004 in research payments were reported against Palforzia (Allergy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $14,010 | 89 |
| 2023 | General | $48,845 | 263 |
| 2022 | General | $414,671 | 2,919 |
| 2022 | Research | $1,356,788 | 405 |
| 2021 | General | $160,164 | 1,457 |
| 2021 | Research | $2,797,752 | 1,170 |
| 2020 | General | $254,366 | 678 |
| 2020 | Research | $3,545,463 | 1,094 |
Breakdown
The top 5 of 88 recipients; each share is of general payments naming this product in 2024.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 27 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
5,406 general · 2,669 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.